Merck has reached an agreement with Dr. Falk Pharma to discontinue an existing contract concerning co-development and co-commercialization rights in certain territories for MK-8690.

Magnet Biomedicine, a biopharmaceutical company, has appointed Bharat Reddy, Ph.D., as its new Chief Business Officer.

Boehringer Ingelheim and CDR-Life have announced a new global licensing agreement to develop CDR-Life’s CDR111 for autoimmune diseases.

Strategic financing will advance development of sac-TMT while Merck continues to progress its expansive pipeline.

Kaigene Inc. has entered into an exclusive global licensing agreement with Celltrion Inc. for two of Kaigene's nonclinical-stage assets, KG006 and KG002.

The Merck Foundation has launched the Collaborative for Equity in Cardiac Care, a $22 million, five-year initiative.

Circle Pharma Inc., a clinical-stage biopharmaceutical company, has appointed Rob Lauzen as Chief Financial Officer (CFO).

Sotio Biotech, a clinical-stage biopharmaceutical company owned by PPF Group, promoted Vivi Boura, M.D., Ph.D., an oncologist with experience leading the clinical development of novel cancer therapies ...

G-Rex based manufacturing process to produce gene-modified regulatory T cell (Treg) therapies for autoimmune disorders ...

Ardena, a CDMO and CRO, has appointed Dipesh Patel as Chief Quality Officer and Peter Rose as Chief Information Officer.

Ajinomoto Co., Inc. has signed a licensing agreement with Astellas Pharma Inc. for the use of AJICAP—an antibody-drug conjugate (ADC) development and manufacturing technology—as part of its CDMO ...

Eli Lilly and Company has announced plans to invest more than $1.2 billion to expand and modernize its Lilly del Caribe manufacturing site in Puerto Rico.